Cytokeratin 19 (CK19) represents the type I acidic cytokeratins that are expressed in many epithelial malignancies, such as lung cancer, breast cancer, cervical carcinoma, colorectal carcinoma and papillary thyroid carcinoma [28, 29]. This evidence concerns the gene KRT19 and lung cancer.